Compare Humana Inc (HUM) vs Nutanix Inc (NTNX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Nutanix Inc — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Nutanix Inc trades at $64.41 (market cap $17.42B). The key difference: Humana Inc is far larger — about 2.7× Nutanix Inc's market cap, and Humana Inc pays a 0.92% dividend while Nutanix Inc pays none. Which is the better fit depends on your goals.
| HUM | NTNX | |
|---|---|---|
Market Cap | $46.31B | $17.42B |
Sector | Health | Technology |
52-Week High | $409.42 | $81.12 |
52-Week Low | $163.67 | $34.41 |
Enterprise Value | $53.67B | $16.94B |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Nutanix (NTNX) trades at $62.67, up 4.24% today, with strong technical and fundamental momentum. The stock is near its 52-week high, supported by bullish moving averages and consistent earnings beats. Revenue growth is robust, with 2026 revenue projected at $2.7B and net profit margin improving to 10.03%. Recent news highlights institutional buying and positive analyst coverage, with 62.5% of analysts rating it a Buy.
Outlook remains positive due to earnings momentum and institutional interest, but risks include high valuation multiples and competitive pressures. The consensus price target is $57.80, slightly below current levels, suggesting near-term consolidation may occur. Investors should weigh growth prospects against elevated P/E and P/S ratios.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →
